Cargando…
ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides
Viruses represent one of the greatest threats to human health, necessitating the development of new antiviral drug candidates. Antiviral peptides often possess excellent biological activity and a favourable toxicity profile, and therefore represent a promising field of novel antiviral drugs. As the...
Autores principales: | Timmons, Patrick Brendan, Hewage, Chandralal M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575049/ https://www.ncbi.nlm.nih.gov/pubmed/34297817 http://dx.doi.org/10.1093/bib/bbab258 |
Ejemplares similares
-
APPTEST is a novel protocol for the automatic prediction of peptide tertiary structures
por: Timmons, Patrick Brendan, et al.
Publicado: (2021) -
HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks
por: Timmons, Patrick Brendan, et al.
Publicado: (2020) -
Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs
por: Xie, Dafei, et al.
Publicado: (2022) -
The substitution spectra of coronavirus genomes
por: Forni, Diego, et al.
Publicado: (2021) -
Roles of host small RNAs in the evolution and host tropism of coronaviruses
por: Meng, Qingren, et al.
Publicado: (2021)